Omnicell Inc (OMCL) 33.19 $OMCL
16.6% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Wed Dec 10, 9:27AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on October 28th, 2014 at $29.08. In approximately 1 month, Omnicell has returned 16.64% as of today's recent price of $33.92.
OMCL: 33.19 (-0.25)
Strong And Under The Radar Today: Omnicell (OMCL)
at The Street - Fri Dec 05, 8:50AM CST
Trade-Ideas LLC identified Omnicell (OMCL) as a strong and under the radar candidate
OMCL: 33.19 (-0.25)
Omnicell Reveals "Take on Tomorrow" Initiative at ASHP Mid-Year Meeting
PR Newswire - Thu Dec 04, 7:00AM CST
Omnicell, Inc., (NASDAQ: OMCL), today announced the "Take on Tomorrow" initiative for 2015, demonstrating the company's commitment to solve medication management compliance challenges, and expand the reach of central pharmacy to satellite and post-acute settings. Omnicell's presence at the American Society of Health-System Pharmacists 2014 Mid-Year Meeting in Anaheim is highlighted by multiple events and demonstrations to illustrate what "tomorrow" will look like as pharmacists advance their role in driving enriched patient care.
OMCL: 33.19 (-0.25)
Don't Miss Today's Strong And Under The Radar Stock: Omnicell (OMCL)
at The Street - Wed Nov 26, 8:48AM CST
Trade-Ideas LLC identified Omnicell (OMCL) as a strong and under the radar candidate
OMCL: 33.19 (-0.25)
Omnicell To Present At The 26th Annual Piper Jaffray Health Care Conference
PR Newswire - Tue Nov 25, 7:00AM CST
Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 26th Annual Piper Jaffray Health Care Conference at the New York Palace Hotel, New York, NY.
OMCL: 33.19 (-0.25)
Omnicell Offers Advanced OT Automation at Hospital in Riyadh - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 2:30PM CST
Per the deal, KFSH&RC will now use Omnicell's (OMCL) Anesthesia Workstation in 37 operating theatres across the hospital thus expanding its installation of Omnicell products
ANIP: 54.28 (+2.33), AMAG: 40.04 (-0.79), OMCL: 33.19 (-0.25), AFFX: 8.94 (-0.36)
Omnicell and King Faisal Specialist Hospital and Research Centre Collaborate to Deliver Excellence in Automation
PR Newswire - Tue Nov 18, 7:00AM CST
Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced that King Faisal Specialist Hospital and Research Center (KFSH&RC) in Riyadh has now expanded its installation of Omnicell products to include full use of Omnicell's Anesthesia Workstation(TM) in 37 operating theatres throughout the hospital to be the first hospital in the region fully automating its operating room medication and supply management. The health care facility replaced a competitive legacy system with the Omnicell Anesthesia Workstation due to Omnicell's experienced local support capabilities and the company's track record for continually improving its technology to meet the needs of growing health care systems. KFSH&RC also recently selected Omnicell as its automation partner for the new 23-floor King Abdullah Centre for Oncology and Liver Diseases (KACO&LD).
OMCL: 33.19 (-0.25)
Earnings Look Back: Omnicell Is Up 7.1% Since Reporting Quarterly Results 2 Weeks Ago (OMCL)
Comtex SmarTrend(R) - Mon Nov 17, 1:22PM CST
Two weeks ago on October 30th, 2014 Omnicell (NASDAQ:OMCL) reported earnings and analysts, on average, expected earnings of $0.31 on sales of $105.9 million. Omnicell actually reported earnings of $0.30 per share on sales of $112.5 million, missing EPS estimates by $0.01 and beating revenue estimates by $6.7 million. Since the company's report, shares of Omnicell have risen from $30.11 to $32.26, representing a gain of 7.1% in the past 18 days.
OMCL: 33.19 (-0.25)
Omnicell Has Returned 11.9% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Nov 14, 10:05AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on October 28th, 2014 at $29.08. In approximately 2 weeks, Omnicell has returned 11.90% as of today's recent price of $32.54.
OMCL: 33.19 (-0.25)
Omnicell Reports Mixed Q3, Positive on Surgichem Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 2:00PM CST
On Nov 6, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.00 (+0.11), ICUI: 80.95 (-1.04), ABAX: 57.20 (+0.61), OMCL: 33.19 (-0.25)
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Omnicell Is Up 5.9% (OMCL)
Comtex SmarTrend(R) - Mon Nov 10, 12:13PM CST
11 days ago, on October 30th, 2014, Omnicell (NASDAQ:OMCL) reported its earnings. Analysts, on average, expected earnings of $0.31 per share on sales of $105.9 million. The company actually reported EPS of $0.30 on sales of $112.5 million, missing EPS estimates by $0.01 and beating revenue estimates by $6.7 million. Since the company's report, shares of Omnicell have risen from $30.11 to $31.89, representing a gain of 5.9% in the past 11 days.
OMCL: 33.19 (-0.25)
Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.00 (+0.11), ICUI: 80.95 (-1.04), ABAX: 57.20 (+0.61), OMCL: 33.19 (-0.25)
Update: Omnicell Q3 Earnings Send Shares Soaring
Marshall Hargrave - at Seeking Alpha - Wed Nov 05, 9:57AM CST
OMCL: 33.19 (-0.25)
Omnicell To Present At The 2014 Stephens Inc. Fall Investment Conference
PR Newswire - Wed Nov 05, 7:17AM CST
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced it will present at the 2014 Stephens Inc. Fall Investment Conference at the New York Palace Hotel, New York, NY.
OMCL: 33.19 (-0.25)
Omnicell Launches Its First Fully Automated Multimed Packing Solution, Driving Workflow Efficiency, Patient Adherence, and Pharmacy Growth
PR Newswire - Wed Nov 05, 7:00AM CST
Omnicell, Inc., (NASDAQ:OMCL), today announced the company's first fully automated multimed packing solution to assist pharmacists in improving their patients' medication adherence. The Omnicell M5000 system is designed to automatically pack, seal, verify and label multimed blister cards for institutional pharmacies serving long term care facilities, retail pharmacies and hospital pharmacies serving ambulatory and discharged patients.
OMCL: 33.19 (-0.25)
Saratoga Hospital Selects Omnicell Unity Enterprise Platform to Upgrade Existing Medication Automation Solutions
PR Newswire - Tue Nov 04, 7:00AM CST
Omnicell, Inc., (NASDAQ: OMCL), today announced that Saratoga Hospital, located in Saratoga Springs, New York, has selected Omnicell to be its new provider of automated medication management solutions and data analytics tools in the main hospital facility as well as an urgent care center, surgery center, infusion center and cancer treatment center. For the first time, from a single central pharmacy location, several different medication dispensing systems can be managed at Saratoga Hospital, providing greater efficiency to clinical and administrative staff.
OMCL: 33.19 (-0.25)
Omnicell Gains Despite Earnings Miss; View Up on High Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:20AM CST
Omnicell's (OMCL) share prices have climbed 7.3% since the earnings release to close at $32.31 on Friday
AMSG: 49.11 (-0.28), USPH: 40.73 (-0.05), RDNT: 8.56 (+0.03), OMCL: 33.19 (-0.25)
Omnicell misses 3Q profit forecasts
Automated Insights - Thu Oct 30, 6:37PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported profit of $7.3 million in its third quarter.
OMCL: 33.19 (-0.25)
Omnicell's (OMCL) CEO Randall Lipps on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:30PM CDT
OMCL: 33.19 (-0.25)
Omnicell misses by $0.01
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:34PM CDT
OMCL: 33.19 (-0.25)
16.6% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Wed Dec 10, 9:27AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on October 28th, 2014 at $29.08. In approximately 1 month, Omnicell has returned 16.64% as of today's recent price of $33.92.
OMCL: 33.19 (-0.25)
Strong And Under The Radar Today: Omnicell (OMCL)
at The Street - Fri Dec 05, 8:50AM CST
Trade-Ideas LLC identified Omnicell (OMCL) as a strong and under the radar candidate
OMCL: 33.19 (-0.25)
Omnicell Reveals "Take on Tomorrow" Initiative at ASHP Mid-Year Meeting
PR Newswire - Thu Dec 04, 7:00AM CST
Omnicell, Inc., (NASDAQ: OMCL), today announced the "Take on Tomorrow" initiative for 2015, demonstrating the company's commitment to solve medication management compliance challenges, and expand the reach of central pharmacy to satellite and post-acute settings. Omnicell's presence at the American Society of Health-System Pharmacists 2014 Mid-Year Meeting in Anaheim is highlighted by multiple events and demonstrations to illustrate what "tomorrow" will look like as pharmacists advance their role in driving enriched patient care.
OMCL: 33.19 (-0.25)
Don't Miss Today's Strong And Under The Radar Stock: Omnicell (OMCL)
at The Street - Wed Nov 26, 8:48AM CST
Trade-Ideas LLC identified Omnicell (OMCL) as a strong and under the radar candidate
OMCL: 33.19 (-0.25)
Omnicell To Present At The 26th Annual Piper Jaffray Health Care Conference
PR Newswire - Tue Nov 25, 7:00AM CST
Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 26th Annual Piper Jaffray Health Care Conference at the New York Palace Hotel, New York, NY.
OMCL: 33.19 (-0.25)
Omnicell Offers Advanced OT Automation at Hospital in Riyadh - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 2:30PM CST
Per the deal, KFSH&RC will now use Omnicell's (OMCL) Anesthesia Workstation in 37 operating theatres across the hospital thus expanding its installation of Omnicell products
ANIP: 54.28 (+2.33), AMAG: 40.04 (-0.79), OMCL: 33.19 (-0.25), AFFX: 8.94 (-0.36)
Omnicell and King Faisal Specialist Hospital and Research Centre Collaborate to Deliver Excellence in Automation
PR Newswire - Tue Nov 18, 7:00AM CST
Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced that King Faisal Specialist Hospital and Research Center (KFSH&RC) in Riyadh has now expanded its installation of Omnicell products to include full use of Omnicell's Anesthesia Workstation(TM) in 37 operating theatres throughout the hospital to be the first hospital in the region fully automating its operating room medication and supply management. The health care facility replaced a competitive legacy system with the Omnicell Anesthesia Workstation due to Omnicell's experienced local support capabilities and the company's track record for continually improving its technology to meet the needs of growing health care systems. KFSH&RC also recently selected Omnicell as its automation partner for the new 23-floor King Abdullah Centre for Oncology and Liver Diseases (KACO&LD).
OMCL: 33.19 (-0.25)
Earnings Look Back: Omnicell Is Up 7.1% Since Reporting Quarterly Results 2 Weeks Ago (OMCL)
Comtex SmarTrend(R) - Mon Nov 17, 1:22PM CST
Two weeks ago on October 30th, 2014 Omnicell (NASDAQ:OMCL) reported earnings and analysts, on average, expected earnings of $0.31 on sales of $105.9 million. Omnicell actually reported earnings of $0.30 per share on sales of $112.5 million, missing EPS estimates by $0.01 and beating revenue estimates by $6.7 million. Since the company's report, shares of Omnicell have risen from $30.11 to $32.26, representing a gain of 7.1% in the past 18 days.
OMCL: 33.19 (-0.25)
Omnicell Has Returned 11.9% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Nov 14, 10:05AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on October 28th, 2014 at $29.08. In approximately 2 weeks, Omnicell has returned 11.90% as of today's recent price of $32.54.
OMCL: 33.19 (-0.25)
Omnicell Reports Mixed Q3, Positive on Surgichem Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 2:00PM CST
On Nov 6, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.00 (+0.11), ICUI: 80.95 (-1.04), ABAX: 57.20 (+0.61), OMCL: 33.19 (-0.25)
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Omnicell Is Up 5.9% (OMCL)
Comtex SmarTrend(R) - Mon Nov 10, 12:13PM CST
11 days ago, on October 30th, 2014, Omnicell (NASDAQ:OMCL) reported its earnings. Analysts, on average, expected earnings of $0.31 per share on sales of $105.9 million. The company actually reported EPS of $0.30 on sales of $112.5 million, missing EPS estimates by $0.01 and beating revenue estimates by $6.7 million. Since the company's report, shares of Omnicell have risen from $30.11 to $31.89, representing a gain of 5.9% in the past 11 days.
OMCL: 33.19 (-0.25)
Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.00 (+0.11), ICUI: 80.95 (-1.04), ABAX: 57.20 (+0.61), OMCL: 33.19 (-0.25)
Update: Omnicell Q3 Earnings Send Shares Soaring
Marshall Hargrave - at Seeking Alpha - Wed Nov 05, 9:57AM CST
OMCL: 33.19 (-0.25)
Omnicell To Present At The 2014 Stephens Inc. Fall Investment Conference
PR Newswire - Wed Nov 05, 7:17AM CST
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced it will present at the 2014 Stephens Inc. Fall Investment Conference at the New York Palace Hotel, New York, NY.
OMCL: 33.19 (-0.25)
Omnicell Launches Its First Fully Automated Multimed Packing Solution, Driving Workflow Efficiency, Patient Adherence, and Pharmacy Growth
PR Newswire - Wed Nov 05, 7:00AM CST
Omnicell, Inc., (NASDAQ:OMCL), today announced the company's first fully automated multimed packing solution to assist pharmacists in improving their patients' medication adherence. The Omnicell M5000 system is designed to automatically pack, seal, verify and label multimed blister cards for institutional pharmacies serving long term care facilities, retail pharmacies and hospital pharmacies serving ambulatory and discharged patients.
OMCL: 33.19 (-0.25)
Saratoga Hospital Selects Omnicell Unity Enterprise Platform to Upgrade Existing Medication Automation Solutions
PR Newswire - Tue Nov 04, 7:00AM CST
Omnicell, Inc., (NASDAQ: OMCL), today announced that Saratoga Hospital, located in Saratoga Springs, New York, has selected Omnicell to be its new provider of automated medication management solutions and data analytics tools in the main hospital facility as well as an urgent care center, surgery center, infusion center and cancer treatment center. For the first time, from a single central pharmacy location, several different medication dispensing systems can be managed at Saratoga Hospital, providing greater efficiency to clinical and administrative staff.
OMCL: 33.19 (-0.25)
Omnicell Gains Despite Earnings Miss; View Up on High Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:20AM CST
Omnicell's (OMCL) share prices have climbed 7.3% since the earnings release to close at $32.31 on Friday
AMSG: 49.11 (-0.28), USPH: 40.73 (-0.05), RDNT: 8.56 (+0.03), OMCL: 33.19 (-0.25)
Omnicell misses 3Q profit forecasts
Automated Insights - Thu Oct 30, 6:37PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported profit of $7.3 million in its third quarter.
OMCL: 33.19 (-0.25)
Omnicell's (OMCL) CEO Randall Lipps on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:30PM CDT
OMCL: 33.19 (-0.25)
Omnicell misses by $0.01
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:34PM CDT
OMCL: 33.19 (-0.25)
